United Kingdom· GB-APID-42339911000001100
Colicym 1million unit powder for nebuliser solution unit dose vials
A medicinal product containing colistin, registered in United Kingdom by Kent Pharma (UK) Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Colistin
- Manufacturer
- Kent Pharma (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5208063005054
- gtin5208063005061
- gtin5208063005078
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Colistin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2c0ef71-5d98-439d-9fa7-13e5f24f0fbd GET /v1/drugs/a2c0ef71-5d98-439d-9fa7-13e5f24f0fbd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42339911000001100",
"desc": "Colicym 1million unit powder for nebuliser solution unit dose vials (Kent Pharma (UK) Ltd)",
"form": "Powder for nebuliser solution",
"vpid": "4256011000001107",
"source": "dmd",
"vtm_id": "775373006",
"strength": "1000000 unit",
"substance": "Colistin",
"ingredient": "Colistimethate sodium",
"supplier_code": "2073701000001100"
}See everything about colistin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.